NIH Says It Is ‘Simplifying’ Funding. What It Is Really Doing Is Handing Science a Gag Order.

The newsroom fluorescents feel extra cruel today. Stale coffee. Printer paper. My tabs are stacked like subpoenas. Somewhere, a lab tech is refreshing the grants portal like it is a heart monitor. Somewhere else, a political appointee is refreshing a spreadsheet like it is a slot machine.

This is what it sounds like when public health gets slowly turned into a controlled substance.

NIH moves away from agency-directed funding calls, leaving fewer than a dozen in early 2026

A policy tracker from the American Association for Cancer Research charts a collapse in NIH Notices of Funding Opportunities: an average of about 780 per year from 2016 to 2024, falling to about 73 after President Donald Trump took office in 2025, and down to fewer than a dozen in early 2026. That is not a minor administrative tweak. That is a demolition crew with a press badge.

NIH frames the shift as streamlining. In a March 23 post on its Extramural Nexus site, the agency says it is simplifying the funding landscape and placing more emphasis on investigator-initiated science rather than highly specific calls. Nature reported the same pivot: fewer solicited calls, more unsolicited proposals, and researchers warning that understudied fields could get stranded.

Translation: “Streamlining” means fewer public priorities, more private veto points

Translation: a Notice of Funding Opportunity is not just paperwork. It is a steering wheel.

Targeted calls are NIH saying, in public: these are the gaps, this is where we build capacity, this is the coordinated push. When those calls disappear, the steering wheel gets ripped out and the car still moves. It just moves where the strongest forces push it.

And those forces are not neutral. They are prestige, incumbency, and who can afford to keep a lab alive through a drought. If you want the simple version: fewer targeted calls means fewer chances for the public to demand science the market will not fund.

Here is the mechanism: choke the pipeline, then blame the scientists

Here is the mechanism: you do not have to ban research to kill it. You just have to make it miss payroll.

Replace targeted calls with mostly unsolicited proposals and you get a competition where the winners are the people already funded, already networked into the study sections, already breathing on institutional oxygen. Everyone else gets told to be “resilient.” Like resilience pays the animal facility bill.

NIH says broad opportunities reduce fragmentation and let innovative ideas flourish. The lived version is that the absence of targeted calls widens gaps because no one is being paid to fill them.

Follow the money: less public direction, more room for capture

Follow the money: when public priorities get quieter, private priorities get louder.

This is not a secret-handshake conspiracy. It is structural incentive. If NIH stops signaling priority areas through targeted calls, the best-funded private actors gain leverage over what counts as “important.” Meanwhile the work that does not cash out cleanly, environmental health, rare disease infrastructure, long-term cohort studies, community interventions, gets pressed against the boardroom glass.

Nature also reported that solicited calls now face extra layers of approval under the current administration. Translation: public-direction tools become slow, brittle, and easier to block. You do not have to say no. You just add gates until the answer arrives as silence.

The quiet part: privatize the mission without changing the sign

The quiet part is that NIH can remain NIH on paper while its mission gets hollowed out in practice.

The public thinks NIH funds cures. The lab reality is that NIH funds capacity: people, equipment, time, the oxygen of science. Remove the tools that build capacity where the market will not, and you change what questions can survive long enough to be asked.

If this is truly “simpler” and truly “innovation,” it should withstand sunlight. Congress should demand the data behind the collapse in funding calls and order an inspector general style audit of who benefits when targeted priorities disappear.